Lexeo Therapeutics, Inc. (NASDAQ:LXEO – Get Free Report) CEO Richard Nolan Townsend sold 13,133 shares of the stock in a transaction dated Friday, October 17th. The stock was sold at an average price of $8.94, for a total transaction of $117,409.02. Following the sale, the chief executive officer owned 242,118 shares in the company, valued […]

Sionna Therapeutics, Inc. (NASDAQ:SION – Get Free Report) CEO Michael Cloonan sold 14,775 shares of Sionna Therapeutics stock in a transaction dated Wednesday, October 15th. The shares were sold at an average price of $31.11, for a total value of $459,650.25. Following the transaction, the chief executive officer owned 547,343 shares in the company, valued […]